HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 37 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q4 2017. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,132,000 | – | 41,499 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Karst Peak Capital Ltd | 1,349,185 | $43,430,000 | 78.86% |
| AIA Investment Management Private Ltd | 354,035 | $11,396,000 | 2.43% |
| Bellevue Group AG | 400,029 | $12,877,000 | 0.82% |
| Prince Street Capital Management LLC | 81,400 | $2,620,000 | 0.55% |
| PRUDENTIAL PLC | 4,247,748 | $136,735,000 | 0.44% |
| OppenheimerFunds, Inc. | 2,936,797 | $94,536,000 | 0.11% |
| SECTORAL ASSET MANAGEMENT INC | 31,628 | $1,018,000 | 0.11% |
| Tibra Equities Europe Ltd | 27,900 | $898,000 | 0.11% |
| Jabre Capital Partners S.A. | 10,000 | $322,000 | 0.11% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 1,803,955 | $58,069,000 | 0.10% |